The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2022 | The current standard of care for MDS-related cytopenias and how treatment strategies may evolve
In this video, Valeria Santini, MD, University of Florence, Florence, Italy, shares some insights into the current standard of care (SOC) for myelodysplastic syndrome (MDS)-related cytopenias and highlights potential therapeutic strategies for these. This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Novartis, AbbVie, BMS, Gilead, Menarini, Geron, Otsuka: Honoraria.
